While studying the tumor microenvironment of this patient population, we found that in RDEB patients affected by cSCC, the expression of CD4 lymphocytes is lower than in the peritumoral infiltrate found in primary cSCC and in RDEB patients with pseudoepitheliomatous hyperplasia. The gene discussed is CD4; the disease is skin squamous cell carcinoma.